GleamWall
中文EN

LH LABCORP HOLDINGS INC.

Services-Medical Laboratories · NYSE · SEC CIK 920148 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.0%
TTM net income YoY17.4%
TTM EPS YoY19.7%
Revenue 3-yr CAGR6.6%
Net income 3-yr CAGR14.9%

Margins

Gross margin29.0%
Operating margin10.3%
Net margin6.9%
FCF margin8.8%
EBITDA margin15.1%

Returns

ROE11.4%
ROA5.4%
ROIC (approx.)8.6%
Asset turnover0.78x

Leverage & solvency

Liabilities / assets53.2%
Debt / equity0.66x
Current ratio1.41x
Interest coverage6.52x

Cash quality & payout

Operating cash flow / net income1.81x
Accruals ratio-4.4%
Payout ratio23.6%
Capex / revenue3.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$13.95B$13.01B
Cost of revenue$9.94B$9.38B
Gross profit$4.01B$3.62B
SG&A expense$2.22B$2.23B
Operating income$1.38B$1.09B
Interest expense$224.10M$208.30M
Pretax income$728.90M$629.70M
Income tax$229.80M$212.40M
Net income$876.50M$746.00M
EBITDA$2.07B$1.73B
EPS (basic)10.548.89
EPS (diluted)10.468.84
Dividends declared per share2.882.88
Weighted avg. shares (diluted)83.80M84.40M
Balance sheet
Cash & equivalents$532.30M$1.52B
Receivables$2.10B$1.94B
Inventory$534.70M$493.20M
Current assets$4.02B$4.81B
PP&E, net$3.08B$3.05B
Goodwill$6.79B$6.37B
Intangibles$3.60B$3.49B
Total assets$18.39B$18.38B
Current liabilities$2.82B$3.33B
Short-term debt$500.10M$1.00B
Long-term debt$5.08B$5.33B
Total debt$5.58B$6.33B
Total liabilities$9.76B$10.31B
Shareholders' equity$8.62B$8.05B
Net debt$5.05B$4.81B
Shares outstanding82.20M83.40M
Cash flow statement
Operating cash flow$1.64B$1.59B
Capital expenditure$434.50M$489.90M
Free cash flow$1.21B$1.10B
Investing cash flow-$1.19B-$1.37B
Financing cash flow-$1.46B$779.90M
Depreciation & amortization$681.10M$643.50M
Stock-based compensation$125.80M$116.70M
Dividends paid$240.70M$243.10M
Share buybacks$450.00M$250.10M

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.